Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The investigators proposal is ripe for executing as the investigators seek to leverage this "natural experiment" initiated by the BJC health system to evaluate the effectiveness of the Pink & Pearl Campaign as an implementation strategy to promote lung cancer screening (LCS) uptake among LCS-eligible women undergoing mammography at BJC West County. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, the research questions and specific aims for this proposal are to: a) evaluate the baseline prevalence of LCS among LCS-eligible women; b) assess whether the Pink & Pearl Campaign increases referrals and uptake/ completion of LCS among LCS-eligible women undergoing screening mammography; and c) evaluate individual and environmental factors influencing LCS uptake, and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Participants - scheduled for mammography and eligible for LCS | Women who are scheduled for mammography and are potentially LCS-eligible will be approached by the registration team and will complete a survey. Subjects who were referred for LCS will be contacted and the investigators will gauge their interest in returning for dual breast and lung screening program in future and rate their experience on a patient satisfaction scale. | ||
| Providers | Providers in the breast radiology service who referred women to LCS. Investigators will gather information on the feasibility, acceptability, and appropriateness of the Pink and Pearl project. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prevalence of LCS-eligible women who opt-in to, and successfully, complete LCS mammography and opt-in to lung cancer screening | At baseline | |
| Number of women screened for LCS | At 3 months | |
| Number of women screened for LCS | At 6 months | |
| Feasibility of Pink and Pearl project | Feasibility is defined as the extent to which the strategy is suitable for routine use in a setting. Information on the feasibility of the Pink and Pearl campaign from healthcare providers will be collected using in-depth interviewing. | At 6 months |
| Acceptability of Pink and Pearl project | Acceptability is defined as the perception that the strategy is agreeable or satisfactory. Information on the acceptability of the Pink and Pearl campaign from healthcare providers will be collected using in-depth interviewing. | At 6 months |
| Appropriateness of Pink and Pearl project | Appropriateness is defined as the perceived fit, relevance, or compatibility of the strategy or practice for a given setting. Information on the appropriateness of the Pink and Pearl campaign from healthcare providers will be collected using in-depth interviewing. | At 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Median time to lung cancer screening | Through completion of follow-up (estimated to be 1 year) | |
| Number of women who have a positive lung radiology screening | Through completion of follow-up (estimated to be 1 year) |
Not provided
Inclusion Criteria for Participants:
Exclusion Criteria for Participants:
Diagnosed with a serious health problem that will likely limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
Unable or unwilling to get treatment if lung cancer is found
Eligibility Criteria for Providers:
Not provided
Not provided
Not provided
Women within the BJC West County electronic health record (EHR) who are scheduled to undergo screening mammography and are eligible for LCS, based on 2021 USPSTF guidelines. In addition to patients, healthcare providers involved in the breast radiology service who referred women to the Pink and Pearl project will also be included as study participants for the qualitative in-depth interviews. This group may include medical doctors, nurse practitioners, nurses, nurse navigators, and physician assistants. Up to 15 healthcare providers will be interviewed.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Beryne Odeny, M.D., MPH, Ph.D. | Contact | 314-362-1183 | beryne@wustl.edu |
| Name | Affiliation | Role |
|---|---|---|
| Beryne Odeny, M.D., MPH, Ph.D. | Washington University School of Medicine | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Barnes-Jewish Hospital West County | Recruiting | Creve Coeur | Missouri | 63141 | United States |
Not provided
| Label | URL |
|---|---|
| Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine | View source |
Not provided
Plan to share results interpretations.
For a period of 1 year.
Contact the Principal Investigator or Central Contact Back-up via email.
Not provided
Not provided
| ID | Term |
|---|---|
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
| Rate of follow-up for a positive screening examination | Through completion of follow-up (estimated to be 1 year) |
| False positive rates | Through completion of follow-up (estimated to be 1 year) |
| Invasive intervention rate | Invasive interventions are considered percutaneous cytologic examination or biopsy, bronchoscopy, surgical procedure mediastinoscopy/otmy, and thorascopy/otmy. | Through completion of follow-up (estimated to be 1 year) |
| Cancer yield rate | Through completion of follow-up (estimated to be 1 year) |
| Adverse event rate for screening | Through completion of follow-up (estimated to be 1 year) |
| Number of women with varying Stage (1-4) findings in the lung screening radiology report. | Histologic type (Bronchioloalveolar carcinoma, adenocarcinoma, squamous-cell carcinoma, large-cell carcinoma, non-small-cell carcinoma or other, small-cell carcinoma, carcinoid). | Through completion of follow-up (estimated to be 1 year) |
| Cause of death | Neoplasm of bronchus and lung, other neoplasm, cardiovascular illness, respiratory illness, complications of medical or surgical care, other. | Through completion of follow-up (estimated to be 1 year) |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |